Correlation Between Berkshire Hathaway and XTANT MEDICAL

Can any of the company-specific risk be diversified away by investing in both Berkshire Hathaway and XTANT MEDICAL at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Berkshire Hathaway and XTANT MEDICAL into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Berkshire Hathaway and XTANT MEDICAL HLDGS, you can compare the effects of market volatilities on Berkshire Hathaway and XTANT MEDICAL and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Berkshire Hathaway with a short position of XTANT MEDICAL. Check out your portfolio center. Please also check ongoing floating volatility patterns of Berkshire Hathaway and XTANT MEDICAL.

Diversification Opportunities for Berkshire Hathaway and XTANT MEDICAL

-0.72

Correlation Coefficient

Berkshire Hathaway  XTANT MEDICAL

Pay attention - limited upside

The 3 months correlation between Berkshire and XTANT is -0.72. Overlapping area represents the amount of risk that can be diversified away by holding Berkshire Hathaway and XTANT MEDICAL HLDGS in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on XTANT MEDICAL HLDGS and Berkshire Hathaway is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Berkshire Hathaway are associated (or correlated) with XTANT MEDICAL. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of XTANT MEDICAL HLDGS has no effect on the direction of Berkshire Hathaway i.e., Berkshire Hathaway and XTANT MEDICAL go up and down completely randomly.

Pair Corralation between Berkshire Hathaway and XTANT MEDICAL

Assuming the 90 days trading horizon Berkshire Hathaway is expected to generate 0.29 times more return on investment than XTANT MEDICAL. However, Berkshire Hathaway is 3.43 times less risky than XTANT MEDICAL. It trades about -0.34 of its potential returns per unit of risk. XTANT MEDICAL HLDGS is currently generating about -0.22 per unit of risk. If you would invest  45,870  in Berkshire Hathaway on September 23, 2024 and sell it today you would lose (2,170) from holding Berkshire Hathaway or give up 4.73% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Berkshire Hathaway  vs.  XTANT MEDICAL HLDGS

Berkshire Hathaway

Risk-Adjusted Performance

6 of 100

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Berkshire Hathaway are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of rather fragile basic indicators, Berkshire Hathaway may actually be approaching a critical reversion point that can send shares even higher in January 2025.

XTANT MEDICAL HLDGS

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days XTANT MEDICAL HLDGS has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fragile performance in the last few months, the Stock's basic indicators remain nearly stable which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long-run up-swing for the company stockholders.

Pair Trading with Berkshire Hathaway and XTANT MEDICAL

The main advantage of trading using opposite Berkshire Hathaway and XTANT MEDICAL positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Berkshire Hathaway position performs unexpectedly, XTANT MEDICAL can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in XTANT MEDICAL will offset losses from the drop in XTANT MEDICAL's long position.

The idea behind Berkshire Hathaway and XTANT MEDICAL HLDGS pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.